Mio Kurata
Nagakute, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.
Journal: Blood advances
Published: May 05, 2026
Maintenance Treatment With Gilteritinib Suppresses Post-transplant Relapse in Relapse/Refractory FLT3-Mutated Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: February 14, 2026
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry.
Journal: Transplantation and cellular therapy
Published: March 26, 2024
Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation.
Journal: Bone marrow transplantation
Published: April 16, 2022
Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.
Journal: Bone marrow transplantation
Published: April 15, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Journal: International journal of hematology
Published: October 22, 2021
Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation-A Matched-Pair Analysis.
Journal: Transplantation and cellular therapy
Published: July 19, 2021
Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016.
Journal: Journal of clinical immunology
Published: May 11, 2021
Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
Journal: Journal of clinical immunology
Published: November 24, 2020
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Journal: Cancer science
Published: November 24, 2020
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: January 11, 2018
Last Updated: 09/26/2026